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susceptible insect strains, and by identification of corresponding genes that display higher expression level in resistant insects (Bautista et al., 2007; Chareonviriyaphap et al., 2003; Tomita et al., 1995; Yaicharoen et al., 2005) . Examinations in various insects such as house fly, cotton ballworm, and mosquito have implicated involvement of up-regulation of different P450 genes in pyrethroid resistance (Liu & Scott, 1998; Müller et al., 2007; Ranasinghe & Hobbs, 1998; Rodpradit et al., 2005; Tomita et al., 1995) . Such P450 overexpression has been assumed constituting a defense mechanism against insecticides and responsible for insecticide resistance, presumably by virtue of enhanced insecticide detoxification. Recent advanced methods employing microarray-based approach, when genomic sequence information for insects is available, have identified multiple genes involved in pyrethroid resistance in mosquitoes. Genes in CYP6 family, in particular, are reported to have an implication in insecticide resistance. In Anopheles gambiae malaria vector, microarray analyses reveal that several CYP6 P450 genes could contribute to pyrethroid resistance, these include CYP6M2, CYP6Z2 and CYP6P3 (Djouaka et al., 2008; Müller et al., 2007) . These genes were observed up-regulated in pyrethroid resistant mosquitoes (Müller et al., 2008; Stevenson et al., 2011) . CYP6M2 and CYP6P3 have shown ability to bind and metabolize pyrethroids, on the other hand CYP6Z2 is able to bind pyrethroids but does not degrade pyrethroids (Mclauglin et al., 2008) . Genetic mapping of genes conferring pyrethroid resistance in An. gambiae also supports involvement of CYP6P3 in pyrethroid resistance (Wondji et al., 2007) . Up-regulation of CYP6 genes has also been found in other resistant insects, for instance CYP6BQ9 in pyrethroid resistant Tribolium castaneum (Zhu et al., 2010) , CYP6D1 in Musca domestica that is able to metabolize pyrethroids (Zhang & Scott, 1996) , and CYP6BG1 in pyrethroid resistant Plutella xylostella (Bautista et al., 2007) . In T. castaneum knockdown of CYP6BQ9 by dsRNA resulted in decreased resistance to deltamethrin (Zhu et al., 2010) . Similar finding has been observed for CYP6BG1 in permethrin resistant P. xylostella, supporting the role of overexpression of these CYP6 genes in pyrethroid resistance (Bautista et al., 2009) . In An. minimus mosquito, CYP6AA3 and CYP6P7 are upregulated and possess activities toward pyrethroid degradation (Duangkaew et al., 2011b; .
Cytochrome P450 monooxygenase (P450) and NADPH-cytochrome P450 reductase (CYPOR) enzymes isolated from An. minimus
In this chapter, we focus on investigation of the P450s that have been shown overexpressed in a laboratory-selected pyrethroid resistant An. minimus mosquito. We describe heterologous expression of the overexpressed P450s in baculovirus-mediated insect cell expression system and characterization of their catalytic roles toward pyrethroid insecticides. Tools utilized in functional investigation of An. minimus P450s have been developed and described. In parallel the An. minimus CYPOR has been cloned and protein expressed via bacterial expression system. Amino acid sequence of An. minimus CYPOR is intrigue in that several important residues that might play role in its functioning as P450 redox partner are different from those of previously reported enzymes from mammals and house fly. The An. minimus CYPOR is different in enzymatic properties and kinetic mechanisms from other CYPORs. In this context we speculate that An. minimus CYPOR could influence electron delivery to target mosquito P450 enzymes, and could act as a ratelimiting step in P450-mediated metabolisms. These results together could thus gain an (Chareonviriyaphap et al., 2002) . Biochemical assays suggested that deltamethrin-resistant An. minimus predominantly employ P450s to detoxify pyrethroids . We next set out on isolation of P450 genes that have a causal linkage in conferring deltamethrin resistance in this mosquito species. Using reversetranscribed-polymerase chain reaction (RT-PCR) in combination with degenerate PCR primers whose sequences were based on CYP6 conserved amino acids, we have isolated CYP6AA3, CYP6P7, and CYP6P8 complete cDNAs from deltamethrin-resistant An. minimus .
The three genes showed elevated transcription level in deltamethrin resistant populations compared to the parent susceptible strain. We found that fold of mRNA increase of CYP6AA3 and CYP6P7 is correlated with increase of resistance during deltamethrin selection. However, this correlation was not observed for CYP6P8 (Rodpradit et al., 2005) . The three mosquito P450s could thus be used as model enzymes for characterization of their metabolic activities toward insecticides and possibly for future development of tools for mosquito vector control. This can be accomplished by determining whether they possess catalytic activities toward pyrethroid insecticides, thus assuming a causal linkage of overexpression and increased pyrethroid detoxification leading to pyrethroid resistance. Equally important, elucidating properties of the An. minimus CYPOR and its influential role in P450 system is beneficial for understanding of P450 metabolisms of this mosquito species.
In vitro insecticide metabolisms
We have heterologously expressed CYP6AA3, CYP6P7, and CYP6P8 in Spodoptera frugiperda (Sf9) insect cells via baculovirus-mediated expression system. The expression procedure employed full-length CYP6AA3, CYP6P7, and CYP6P8 cDNAs as templates to produce recombinant baculoviruses, and subsequently infected Sf9 cells for production of P450 proteins. RT-PCR amplification and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis were performed to verify expression of P450 mRNAs and proteins in the infected Sf9 cells. Expression of CYP6AA3, CYP6P7, and CYP6P8, each is predominantly detected in membrane fractions of infected cells after 72 hours of infection, with expected molecular size of approximately 59 kDa detected on SDS-PAGE (Kaewpa et al., 2007; Duangkaew et al., 2011b) . The expressed proteins display CO-reduced difference spectrum of a characteristic peak at 450 nm (Omura & Sato, 1964) . Total P450 content obtained from baculovirus-mediated expression of CYP6AA3, CYP6P7, and CYP6P8 ranges from 200 to 360 pmol/mg membrane protein. The expressed CYP6AA3, CYP6P7, and CYP6P8 proteins were used in enzymatic reaction assays testing against pyrethroids and other insecticide groups. Knowledge of the metabolic profile of these P450s could give us insight into functioning of these P450s within mosquitoes towards insecticide metabolisms, i.e. how mosquitoes detoxify against a spectrum of insecticide classes through P450-mediated metabolisms. In enzymatic assay, each P450 in the reaction was performed in the presence of NADPHregenerating system and was reconstituted with An.minimus CYPOR (Kaewpa et al., 2007) , as CYPOR is required to supply electrons to P450 in the reaction cycle. Insecticide metabolism was determined by detection of disappearance of insecticide substrate at different times compared with that present at time zero as previously described (Booseupsakul et al., 2008) . This time course degradation was detected through HPLC analysis. Table 1 summarizes enzyme activities of CYP6AA3 and CYP6P7 toward insecticides and metabolites detected. Insecticides that were tested by enzyme assays were type I pyrethroids (permethrin and bioallethrin), type II pyrethroids (deltamethrin, cypermethrin, and λ-cyhalothrin), organophosphate (chlorpyrifos), and carbamate (propoxur). Additional insecticides (bifenthrin, dichlorvos, fenitrothion, temephos, and thiodicarb) belonging to these four insecticide classes were tested by cytotoxicity assays (see Section 2.3). Chemical structures of these insecticides are shown in Fig. 1 The results shown in Table 1 demonstrate that CYP6AA3 and CYP6P7 share overlapping metabolic profile against both type I and II pyrethroids, while no detectable activity was observed toward chlorpyrifos and propoxur (Duangkaew et al., 2011b) , nor in the presence of piperonyl butoxide (a P450 inhibitor). Differences in activities of both enzymes could be noted, for CPY6AA3 could metabolize λ-cyhalothrin while CYP6P7 did not display activity against λ-cyhalothrin. For CYP6P8 we initially detected absence of pyrethroid degradation activity, further tests using cytotoxicity assays described in Section 2.3 suggest that CYP6P8 is not capable of degradation of pyrethroids, organophosphates and carbamates. Determination of products obtained from CYP6AA3-mediated pyrethroid degradations using GC-MS analysis reveal multiple products for type II pyrethroid cypermethrin degradation and for earlier described deltamethrin metabolism (Boonseupsakul et al., 2008) . These products were 3-phenoxybenzyaldehyde and two unknown products with chloride and bromide isotope distribution derived from cypermethrin and deltamethrin metabolisms, respectively. In contrast there was only one unknown product that was predominantly detected from CYP6AA3-mediated permethrin (type I pyrethroid) degradation, with mass spectrum profile showing characteristic chloride isotope distribution of permethrin-derived compound. Unlike cypermethrin and deltamethrin metabolisms, we did not obtain 3-phenoxybenzaldehyde from permethrin degradation (Boonseupsakul, 2008) . Type I and type II pyrethroids are different by the presence of cyano group (see Fig. 1 ). Thus our results implicate that presence of cyano group may play role in CYP6AA3-mediated pyrethroid degradations resulting in detection of 3-phenoxybenzaldehyde, possibly through oxidative cleavage reaction. In An. gambiae CYP6M2-mediated deltamethrin metabolism and house fly CYP6D1-mediated cypermethrin metabolism, 4'-hydroxylation of deltamethrin and cypermethrin is the major route of their metabolisms since 4'-hydroxylation products were predominantly detected (Stevenson et al., 2011; Zhang & Scott, 1996) . The 4'-hydroxylation and 3-phenoxybenzaldehyde products have been observed in in vitro pyrethroid metabolisms mediated by mammalian microsomal enzymes (Shono et al., 1979) . The absence of detection of 3-phenoxybenzaldehyde in CYP6AA3-mediated permethrin degradation could be predicted that the reaction underwent monooxygenation of permethrin.
Characterization of CYP6AA3 and CYP6P7 enzymes
As described, both CYP6AA3 and CYP6P7 enzymes have enzymatic activities against pyrethroid insecticides and their metabolic profiles are different. Kinetics and inhibition studies further support their abilities to metabolize pyrethroids, however with different enzyme and kinetic properties that influence substrate and inhibitor selectivity. Such knowledge could have an implication in pyrethroid detoxification in An. minimus mosquito, for example how the two P450s redundantly metabolize overlapping sets of pyrethroids. Alongside investigation of pyrethroid metabolisms, we examined their activities toward fluorescent compounds for development of rapid enzymatic assays. Finally we performed cell-based MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) cytotoxicity assays for further determination of substrates and inhibitors of both P450 enzymes as reported herein.
Determination of enzyme kinetics of CYP6AA3 and CYP6P7 enzymes
We recently reported kenetic paremeters for CYP6AA3 and CYP6P7 enzymes (Duangkaew et al., 2011b) . Kinetic results reveal that CYP6AA3 has preference in binding to and has higher rate in degradation of permethrin type I pyrethroid than type II pyrethroids (K m values toward permethrin, cypermethrin, deltamethrin, and λ-cyhalothrin of 41.0 ± 8.5, 70.0 ± 7.1, 80.2 ± 2.0, and 78.3 ± 7.0 µM, respectively and V max values of 124.2 ± 1.2, 40.0 ± 7.1, 60.2 ± 3.6, and 60.7 ± 1.1 pmol/min/pmol P450, respectively). In contradictory CYP6P7 does not have preference for type of pyrethroids (K m values toward permethrin, cypermethrin, and deltamethrin of 69.7 ± 10.5 , 97.3 ± 6.4, and 73.3 ± 2.9, respectively and V max values of 65.7 ± 1.6, 83.3 ± 7.6, and 55.3 ± 5.7 pmol/min/pmol P450, respectively) and does not metabolize λ-cyhalothrin. Thus although both enzymes are comparable in terms of capability to metabolize pyrethroids in vitro, their kinetic values are different. Enzyme structure could account for their differences in kinetic properties and substrate preference. Since there has been no known crystal structure available for insect P450s, we initially constructed homology models for CYP6AA3, CYP6P7, and CYP6P8 in an attempt to increase our understanding of molecular mechanisms underlying their binding sites toward insecticide substrates and inhibitors. The three enzyme models are different in geometry of their active-site cavities and substrate access channels. Upon docking with various insecticide groups, results of its active site could predict and explain metabolic behavior toward pyrethroid, organophosphate, and carbamate insecticides (Lertkiatmongkol et al., 2011) . These results suggest that differences in metabolic activities among P450 enzymes in insects could be attributed to structural differences resulting in selectivity and different enzymatic activities against insecticides. In human, CYP2C8, CYP2C9, CYP2C19, and CYP3A4 have been reported abilities to metabolize both type I and II pyrethroids (Godin et al., 2007; Scollon et al., 2009 ). The preference for type I pyrethroid in CYP6AA3 is similar to human CYP2C9 and CYP2C19, while similar metabolic activity toward both types of pyrethroids found for CYP6P7 is similar to that of human CYP2C8 enzyme (Scollon et al., 2009) . Nevertheless efficiency of CYP6AA3 and CYP6P7 in deltamethrin degradation is 5-to 10-fold less effective than human CYP2C8 and CYP2C19. It is noteworthy that more than one P450s residing within an organism can metabolize pyrethroids as described for human and mosquito, multiple rat P450s are also found capable of pyrethroid metabolisms (Scollon et al., 2009) . When comparing to An. gambiae CYP6P3, both CYP6AA3 and CYP6P7 possess at least 10 fold higher K m than CYP6P3, but V max values of both An. minimus CYP6AA3 and CYP6P7 are at least 20 fold higher (Müller et al., 2008) . Higher values of K m and V max of CYP6AA3 and CYP6P7 than those values of An. gambiae CYP6M2 (Stevenson et al., 2011) are also observed.
CYP6AA3 and CYP6P7 are inhibited differently by different compounds
To obtain a potential fluorogenic substrate probe for fluorescent-based assays of CYP6AA3 and CYP6P7, we previously screened four resorufin fluorogenic substrates containing different alkyl groups (Duangkaew et al., 2011b) and results in Table 2 suggest that among test compounds, benzyloxyresorufin could be used as a fluorescent substrate probe since both CYP6P7 and CYP6AA3 could bind and metabolize benzyloxyresorufin with lowest K m (values of 1.92 for CYP6AA3 and 0.49 for CYP6P7) and with highest specific activities (Duangkaew et al., 2011b) . The assays of benzyloxyresorufin-O-debenzylation activity were further used for inhibition studies of both mosquito enzymes. Table 2 . Specific activities of CYP6AA3 and CYP6P7 toward resorufin derivatives.
Using fluorescence-based assays, we could initially determine what compound types that give mechanism-based inhibition pattern by pre-incubation of enzyme with various concentrations of test inhibitors in the presence or absence of NADPH for 30 min before addition of substrates and IC 50 values have been determined as described (Duangkaew et al., 2011b) . As known, mechanism-based inactivation inhibits enzyme irreversibly, rendering this mechanism of inhibition more efficient than reversible inhibition. Nevertheless information on mode of inhibition for inhibitors is potential for understanding of catalytic nature of enzymes. We thus determined mode of inhibition for all compounds tested. As shown in Table 2 , the compounds we have tested are phenolic compounds and their chemical structures are shown in Fig. 2 . It is apparent that none of test flavonoids and furanocoumarins shows mechanism-based inhibition pattern, but piperonyl butoxide (PBO) and piperine that are methylenedioxyphenyl compounds show NADPH-dependent mechanism-based inhibition activities against both enzymes. Piperine has been commonly found in Piper sp. plant extracts, it possesses acute toxicity to mammals (Daware et al., 2000) . Inhibition results shown in Table 3 also elucidate that -naphthoflavone displayed strongest inhibitory effect. Its inhibition pattern suggests that -naphthoflavone uncompetitively inhibit both enzymes by binding to CYP6AA3-and CYP6P7-benzyloxyresorufin complex. Moreover, a difference was noted for xanthotoxin as it uncompetitively inhibits CYP6AA3 but mixed-type inhibited CYP6P7. Thus inhibition results together with different metabolic profiles thus confirm that CYP6AA3 and CYP6P7 have different enzyme properties. We thus also tested crude extracts of two plants (Citrus reticulate and Stemona spp.) that were reported containing phenolic compounds (Kaltenegger et al., 2003; Jayaprakasha et al., 1997) and are found in Thailand. Initial results suggest that compounds within both plants may not possess mechanism-based activities against CYP6AA3 and CYP6P7, and both extracts did not inhibit both enzymes as efficient as flavonoids and methylenedioxyphenyl compounds. Table 3 . Mode of inhibition and inhibition constants of CYP6P7-or CYP6AA3-benzyloxyresorufin-O-debenzylation activities of flavonoids, furanocoumarins, and MDP compounds (Duangkaew et al., 2011b) . Crude plant extracts reported herein are ethanolic extracts. Values marked with 'a' are significantly different between reactions with (w/) and without (w/o) NADPH. ND, not determined.
Use of cell-based MTT cytotoxicity assays to determine insecticide substrates and inhibitiors of An. minimus P450 enzymes
Since in vitro reconstitution system demonstrated CYP6AA3 and CYP6P7 enzymatic activities against pyrethroids, further investigation of the ability of CYP6AA3 and CYP6P7 enzymes to eliminate pyrethroid toxicity from cells was assessed in P450-infected Sf9 cells. This can be accomplished because other than targeting on sodium channels of nervous system, pyrethroids possess toxic effects on cells such as inhibition of cell mitochondrial complex I or causing DNA damage and cell death (Gassner et al., 1997; Patel et al., 2007; Naravaneni & Jamil, 2005) . Similar cell death and cytotoxic to cells caused by organophosphates and carbamate insecticides have also been reported (Maran et al., 2010; Schmuck & Mihail, 2004) . This is supported by that we previously observed cytotoxic effects of deltamthrin on insect Sf9 cells. When using Sf9 cells that express CYP6AA3 in MTT assays, cell mortality was drastically decreased in the presence of insecticides due to degradation of deltamethrin by CYP6AA3 and thus posing cytoprotective role on Sf9 cells (Boonseupsakul et al., 2008) . Use of insect cells to test for toxicity effects of compounds such as fungal metabolites (Fornelli et al., 2004) and pyridalyl insecticide (Saito et al., 2005) has been previously reported. Moreover, insect cells expressing P450 have also been successfully used to test detoxification capability of enzyme against cytotoxic xenochemicals (Grant et al., 1996; Greene et al., 2000) . In this context, we used MTT assays to determine insecticide detoxification by P450 expressed in Sf9 cells. Insecticides tested were pyrethroids (deltamethrin, permethrin, cypermethrin, bifenthrin, bioallethrin and λ-cyhalothrin), organophosphates (chlorpyrifos, dichlorvos, fenitrothion and temephos), carbamates (thiodicarb and propoxur). Various concentrations (1-500 M) of insecticides were used for determination of cytotoxic effect of insecticides toward CYP6AA3-, CYP6P7-, and CYP6P8-expressing cells and compared to the control parent Sf9 cells. Cell viability of insecticide treated cells was measured by MTT assay as previously described (Boonseupsakul et al., 2008) and plotted against insecticide concentrations. The LC 50 value of each insecticide was subsequently evaluated and obtained from each plot. Table 4 summarizes LC 50 values of insecticides against Sf9 cells and cells with expression of P450s. We observed that pyrethroids, organophosphates and carbamates are toxic to Sf9 parent cells. Since LC 50 values of permethrin, bifenthrin, cypermethrin, and deltamethrin against CYP6AA3-and CYP6P7-expressing cells were approximately 4-to 19-folds significantly greater than those from parent Sf9 cells, these values imply that CYP6AA3 and CYP6P7 enzymes could cytoprotect Sf9 cells from pyrethroid toxicity. Conversely there was no significant difference of IC 50 values between cells treated with organophosphate (chlorpyrifos, fenitrothion and temephos), carbamates (thiodicarb and propoxur) and bioallethrin pyrethroid insecticide, suggesting that expression of P450s did not cytoprotect cells from these insecticides. In addition CYP6P8 did not cytoprotect Sf9 cells against insecticides tested. It should be noted that LC 50 value of λ-cyhalothrin in CYP6AA3-expressing cells was significantly greater than Sf9 parent cells, but not in CYP6P7-expressing cells. These results from MTT cytotoxicity assays are thus in agreement with in vitro enzymatic assays as described in Section 2.1. Thus abilities to cytoprotect against insecticide toxicity in infected Sf9 cells are due to P450-mediated enzymatic activity toward insecticides of CYP6AA3 and CYP6P7 (Duangkaew et al., 2011a) . Together with in vitro enzymatic and cytotoxicity assays, we can conclude that both CYP6AA3 and CYP6P7 share metabolic activities against pyrethroids, but both enzymes play no role in degradations of organophosphates and carbamates. The results suggest that CYP6P8 plays no role in degradation of insecticides tested in this report. Moreover, such cytotoxicity results implicate that the method could also be applied for primary screening of compounds that have an inhibitory effect towards CYP6AA3 and CYP6P7, as well as P450 enzymes that possess enzymatic activities against these insecticides. 4.0 ± 6.6 4.7 ± 0.3 3.6 ± 0.2 ND Thiodicarb 28.6 ± 2.3 29.2 ± 4.7 ND ND Table 4 . Cytotoxicity effects by insecticides on P450-infected cells and the parent SF9 cells using MTT assays. Values reported for CYP6P8 were average obtained from experiments performed in duplicate. Those marked with 'a' were significantly different from parent Sf9 cells and those marked with 'b' were reported in Duangkaew et al, 2011a . ND, not determined.
Insecticides
To test whether inhibitors can be screened, MTT assays were performed with P450-expressing cells treated with 100 M deltamethin in the presence or absence of each test inhibitor. Concentrations of test inhibitory compounds were those of approximately LC 20 values pre-determined by MTT assays on Sf9 cells. In cell-based inhibition assays, cell viability was determined upon co-incubation of test compound and deltamethrin, and normalized with viability of cells treated with test compound without deltamethrin. Inhibition experiments were performed with control Sf9 cells in the same manner as CYP6AA3-expressing cells and percent cell viability was plotted against test inhibitor concentrations, and results demonstrated that cell viability of parent Sf9 cells was not affected by test compounds (data not shown). The results shown in Fig. 3 indicate that cell viability of CYP6AA3-expressing cells was decreased upon increasing concentration of test inhibitors. Piperine, piperonyl butoxide, and -naphthoflavone could inhibit cytoprotective activity of CYP6AA3 more than xanthotoxin. This is thus in compliance with in vitro enzymatic inhibition assays, although piperonyl butoxide showed more potential than -naphthoflavone in inhibiting cytoprotective activity of CYP6AA3. Cell permeability of test compounds could be accounted for differences of cell-based MTT and in vitro enzymatic assays. The results however indicate usefulness of cells expressing P450 enzymes to primarily screen for P450 substrates and inhibitors. Our results indicated that PBO and piperine could inhibit P450s and possess synergistic actions against deltamethrin cytotoxicity in Sf9 cells expressing P450. PBO has been used as pyrethroid synergist to enhance pyrethroid toxicity, as it can bind to P450s thereby inhibiting P450 activity (Fakoorziba et al., 2009; Kumar et al., 2002; Vijayan et al., 2007) . Unfortunately PBO has been reported acutely toxic to mammals (Cox, 2002; Okamiya et al., 1998) . Fig. 3 . Inhibition effect of test compounds against cell-based CYP6AA3-mediated deltamethrin detoxification measured by MTT assays.
An. minimus CYPOR and its possible role in regulation of P450-reaction cycle
The NADPH-Cytochrome P450 oxidoreductase (CYPOR) enzyme is a member of di-flavin enzymes that transfers electrons, one by one, from NADPH through FAD and FMN to target enzymes to fulfill functioning of various cytochrome P450 enzymes as well as other enzymes (Murataliev et al., 2004) . Other members of this class are those containing a flavoprotein subunit, such as nitric oxide synthase, sulfite reductase, methionine synthase reductase and protein NR 1. Detailed biochemical and structural studies of rat CYPOR reveal several conserved structural domains existed in this enzyme class, these are membrane-bound, FMN-binding, connecting, and FAD/NADPH binding domains (Wang et al., 1997) . The An. minimus CYPOR has been cloned and expressed in E. coli, and CYPOR could support CYP6AA3-and CYP6P7-mediated pyrethroid metabolisms in vitro (Duangkaew et al., 2011b; Kaewpa et al., 2007) . However its expression has been of poor yield as a result of inclusion bodies formation. An attempt to obtain soluble protein by deletion of the first 55 amino acid residues comprising of membrane binding region (55AnCYPOR) has been successful (Sarapusit et al., 2008) . However the protein could not be purified by 2'5'-ADP affinity column, indicating that NADPH binding capacity of mosquito CYPOR is low and this is different from CYPORs of other organisms such as rat and human (Sarapusit, 2009) . Low binding affinity to 2'5'-ADP affinity column has also been recently reported in An. gambiae CYPOR (Lian et al., 2011) . Only under specific condition was 55AnCYPOR successfully expressed and purified to homogeneity by a combination of Ni 2+ NTA-affinity chromatography and G200-gel filtration chromatography (Sarapusit et al., 2008) . Moreover both purified full-length (flAnCYPOR) and membrane-deleted 55AnCYPOR proteins readily lose FAD and FMN cofactors, they undergo aggregation and are unstable compared to rat and human CYPORs (Sarapusit et al., 2008 (Sarapusit et al., , 2010 . While supplementation of FAD could increase activity of both full-length and membrane-deleted forms, FMN supplementation could increase activity of full-length form only (Sarapusit et al., 2008 (Sarapusit et al., , 2010 . This behavior is different from membrane-deleted soluble CYPORs of rat and human in which exogenous FMN is readily incorporated into its FMNbinding site (Döhr et al., 2001; Shen et al., 1989) . Due to loss of flavin cofactors and instability of An. minimus CYPOR, we have identified two key amino acids (Leu86 and Leu219 in FMN binding domain) by amino sequence alignment and shown that mutations of the two leucine residues into conserved phenylalanine residues that are found conserved among other CYPORs could rescue loss of FAD cofactor and increase protein stability of mosquito CYPOR (Sarapusit et al., 2008 (Sarapusit et al., , 2010 . These mutations do not affect kinetic mechanism and constants of enzyme. Double mutations of leucine to the conserved phenylalanine (L86F/L219F) in fulllength flAnCYPOR, but not in 55AnCYPOR, could increase binding of FMN and increase CYP6AA3-mediated pyrethroid metabolism (Sarapusit et al., 2010) , indicating that membranebound region of An. minimus CYPOR could influence both structural folding of FMN domain and mediation of P450 catalysis (Murataliev et al., 2004; Wang et al., 1997) .
The enzyme activity and kinetic mechanism of flAnCYPOR using cytochrome c as substrate are ionic strength dependent, with its mechanism following random Bi-Bi mechanism at low ionic strength and non-classical two-side Ping-Pong at high ionic strength. These mechanisms are different from rat, human, and house fly CYPORs (Murataliev et al., 2004; Sem & Kasper, 1994 . In addition, flAnCYPOR could use extra flavins as additional substrates in which FAD binds at FAD/NADPH domain and FMN binds at FMN domain (as depicted in Fig. 4) , resulting in an increase in its rate of electron transfer in CYP6AA3-mediated pyrethroid degradation (Sarapusit et al., 2010) . In Figure 4 , panel A illustrates common CYPOR (such as rat, human CYPORs) to which NADPH and cytochrome c substrate separately binds FAD/NADPH and FMN domains, while in panel B, flAnCYPOR could use extra flavins as additional substrates to which FAD cofactor binds FAD/NADPH domain and FMN cofactor binds FMN domain. We thus speculate that An. minimus mosquito uses CYPOR in regulation of P450-mediated metabolisms, since it supplies electrons to a collection of P450s within the cell. Although structural basis for loose binding of flavin cofactors in An. minimus CYPOR is not known, it is conceivable that its distinct property that adopt extra flavins as substrates may render the enzyme ability to regulate electron transfer to target mosquito enzymes.
Conclusion
The results of this study on CYP6AA3 and CYP6P7 could lay groundwork into an understanding of the mechanisms that control substrates and reaction selectivity of both P450 enzymes, thereby increase an understanding of P450-mediated resistance mechanisms to various pesticides. The kinetic values, metabolic profile of pyrethroid insecticide metabolisms and inhibition patterns by different inhibitors of CYP6AA3 are different from CYP6P7. Future approach could aim at the strategy involving finding a collection of substrates together with structural models and mutation analyses of CYP6AA3 and CYP6P7 that affect specific P450 catalysis. Moreover, characterizing inhibitors and inhibition mechanisms of large collection of compounds with known chemical structures against CYP6AA3 and CYP6P7 enzymes could give insight into an understanding of mechanisms of cytochrome P450s that metabolize pyrethroids. It is conceivable that CYP6P8 does not play role in detoxification of pyrethroid, organophosphate, and carbamate insecticides. Further substrate search for CYP6P8 may help to learn about its overexpression in pyrethroidresistant mosquito. Together with knowledge obtained from enzymatic properties of An. minimus CYPOR, this could improve our understanding of P450-mediated detoxification of insecticides, as well as provide a foundation for rational design of P450 synergists specific for P450-mediated pesticide resistance and thus resistant management in mosquito vector control program.
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